BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37864298)

  • 21. Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA.
    Bishop CL; Ramalho M; Nadkarni N; May Kong W; Higgins CF; Krauzewicz N
    Mol Cell Biol; 2006 Apr; 26(7):2583-94. PubMed ID: 16537904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effects of human umbilical cord mesenchymal stromal cells in PD mice via centrally and peripherally suppressing NLRP3 inflammasome-mediated inflammatory responses.
    Zhou L; Wang X; Wang X; An J; Zheng X; Han D; Chen Z
    Biomed Pharmacother; 2022 Sep; 153():113535. PubMed ID: 36076517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multifunctional biomimetic hydrogel systems to boost the immunomodulatory potential of mesenchymal stromal cells.
    Gonzalez-Pujana A; Vining KH; Zhang DKY; Santos-Vizcaino E; Igartua M; Hernandez RM; Mooney DJ
    Biomaterials; 2020 Oct; 257():120266. PubMed ID: 32763614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation.
    Lin T; Pajarinen J; Kohno Y; Huang JF; Maruyama M; Romero-Lopez M; Nathan K; Yao Z; Goodman SB
    FASEB J; 2019 Mar; 33(3):4203-4211. PubMed ID: 30521384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Immunomodulatory Potential of Mesenchymal Stem Cells in a Retinal Inflammatory Environment.
    Hermankova B; Kossl J; Bohacova P; Javorkova E; Hajkova M; Krulova M; Zajicova A; Holan V
    Stem Cell Rev Rep; 2019 Dec; 15(6):880-891. PubMed ID: 31863334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
    Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
    J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PML modulates epigenetic composition of chromatin to regulate expression of pro-metastatic genes in triple-negative breast cancer.
    Fracassi C; Ugge' M; Abdelhalim M; Zapparoli E; Simoni M; Magliulo D; Mazza D; Lazarevic D; Morelli MJ; Collas P; Bernardi R
    Nucleic Acids Res; 2023 Nov; 51(20):11024-11039. PubMed ID: 37823593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing
    Skibber MA; Olson SD; Prabhakara KS; Gill BS; Cox CS
    Front Immunol; 2022; 13():874698. PubMed ID: 35874742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
    Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
    Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PML is recruited to heterochromatin during S phase and represses DAXX-mediated histone H3.3 chromatin assembly.
    Shastrula PK; Sierra I; Deng Z; Keeney F; Hayden JE; Lieberman PM; Janicki SM
    J Cell Sci; 2019 Mar; 132(6):. PubMed ID: 30796101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D encapsulation and inflammatory licensing of mesenchymal stromal cells alter the expression of common reference genes used in real-time RT-qPCR.
    Gonzalez-Pujana A; de Lázaro I; Vining KH; Santos-Vizcaino E; Igartua M; Hernandez RM; Mooney DJ
    Biomater Sci; 2020 Dec; 8(23):6741-6753. PubMed ID: 33136110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Mesenchymal Stem Cell-Treated Regulatory CD23
    Chen X; Cai C; Xu D; Liu Q; Zheng S; Liu L; Li G; Zhang X; Li X; Ma Y; Huang L; Chen J; Shi J; Du X; Xia W; Xiang AP; Peng Y
    Theranostics; 2019; 9(16):4633-4647. PubMed ID: 31367246
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunomodulatory function of licensed human bone marrow mesenchymal stromal cell-derived apoptotic bodies.
    Wang J; Donohoe E; Canning A; Moosavizadeh S; Buckley F; Brennan MÁ; Ryan AE; Ritter T
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111096. PubMed ID: 37871378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines.
    Ferrari D; Gulinelli S; Salvestrini V; Lucchetti G; Zini R; Manfredini R; Caione L; Piacibello W; Ciciarello M; Rossi L; Idzko M; Ferrari S; Di Virgilio F; Lemoli RM
    Exp Hematol; 2011 Mar; 39(3):360-74, 374.e1-5. PubMed ID: 21145936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine mesenchymal stem cells treated with TNF-α and IFN-γ enhance anti-inflammatory effects through the COX-2/PGE
    Yang HM; Song WJ; Li Q; Kim SY; Kim HJ; Ryu MO; Ahn JO; Youn HY
    Res Vet Sci; 2018 Aug; 119():19-26. PubMed ID: 29783120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal models.
    Liu LN; Wang G; Hendricks K; Lee K; Bohnlein E; Junker U; Mosca JD
    Stem Cells Transl Med; 2013 May; 2(5):362-75. PubMed ID: 23592838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of active and repressive histone marks during adipogenic differentiation of porcine mesenchymal stem cells.
    Stachecka J; Kolodziejski PA; Noak M; Szczerbal I
    Sci Rep; 2021 Jan; 11(1):1325. PubMed ID: 33446668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum from patients with asthma potentiates macrophage phagocytosis and human mesenchymal stromal cell therapy in experimental allergic asthma.
    Abreu S; Alves L; Carvalho L; Xisto D; Blanco N; Castro L; Olsen P; Lapa E Silva JR; Morales MM; Lopes-Pacheco M; Weiss D; Rocco PRM
    Cytotherapy; 2023 Sep; 25(9):967-976. PubMed ID: 37330732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PML nuclear bodies as sites of epigenetic regulation.
    Torok D; Ching RW; Bazett-Jones DP
    Front Biosci (Landmark Ed); 2009 Jan; 14(4):1325-36. PubMed ID: 19273133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.